Developer docs
API playgroundTry for free, no card

Search company profiles

AnteoTech

Full company profile

uuid00068xm

Namestring
AnteoTech
Legal namestring
AnteoTech Ltd
Websiteurl
anteotech.com
Company typeenum
Public
Founded yearint
1995
Descriptiontext

AnteoTech Ltd (ASX: ADO) is a Brisbane-based public company founded in 1995 that operates two distinct technology platforms. In Life Sciences it develops and commercializes diagnostic binding products under the AnteoBind brand, including the next-generation AnteoBind NXT platform expanded into chemiluminescence, serving healthcare, agriculture, and veterinary diagnostics customers such as the Serum Institute. In Advanced Battery Technologies it develops UltraNode silicon anode materials (notably UltraNode 95, with stated capacities of 2,000-2,400 mAh/g versus ~371 mAh/g for graphite, enabling energy densities above 390 Wh/kg), the Anteo X platform, and the Anteo S cross-linking separator product, with go-to-market focus on drone, defense, and medical device battery applications and recent independent validation by the Battery Innovation Center in Indiana. Revenue mechanics combine product sales (AnteoBind diagnostics), licensing/royalty arrangements (battery materials with partners such as Xerobrid), and an end-to-end contract services offering, distributed through a small but expanding network of channel partners including Cosmo Bio in Japan, Black Diamond Structures in the US, and South Korean battery distributors.

The company is small (11-50 employees), headquartered at Brisbane Technology Park in Eight Mile Plains, and has undergone cost-base restructuring alongside an AUD 3.5 million capital raise in early 2026 to extend operational runway and accelerate sales conversion. Strategic activity in mid-2026 has centred on commercialization: an UltraNode 95 product launch, a strategic collaboration with Xerobrid Corporation pairing Anteo S with ceramic-coated separators, a Cosmo Bio distribution deal opening Japan, and JDAs being negotiated with US defense-aligned battery manufacturers. The current share price sits near 52-week lows at AUD 0.012, reflecting investor concern about the speed of revenue conversion, while named partners and validation milestones support an active commercialization pipeline.

Short descriptiontext

AnteoTech is an Australian (ASX: ADO) materials and diagnostics company that develops silicon anode battery technologies (UltraNode, Anteo X, Anteo S) for drone, defense, and medical device applications, and AnteoBind diagnostic binding products for healthcare, agriculture, and veterinary markets, selling via channel partners globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersEight Mile Plains, Australia
HQ citystring
Eight Mile Plains
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
lithium-ion battery materials, silicon anode technology, in vitro diagnostics, battery separator coatings, diagnostic binding agents
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Battery Manufacturing33591
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Advanced Battery Materials & Life Sciences Diagnostics
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Battery Technology Products
TypeLicensing Royalties
Description

Revenue from battery separator technology (Anteo S) and silicon anode products (UltraNode). Strategic collaboration and sales agreement with Xerobrid Corporation for separator technology.

theaustralian.com.au
2Life Sciences Diagnostics
TypeOthers
Description

Revenue from diagnostic products including AnteoBind and AnteoBind NXT, with expansion into chemiluminescence market. Serum Institute order mentioned as key revenue catalyst.

tradingview.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Anteo X
Description

Advanced battery technology product line

anteotech.com
+3 more records
Core offering1 text field

AnteoTech develops and commercializes two technology platforms: (1) Advanced Battery Technologies, including silicon anode materials (Ultranode/UltraNode 95), a battery technology platform (Anteo X), and a cross-linking separator product (Anteo S); and (2) Life Sciences diagnostics, including the AnteoBind platform and next-generation AnteoBind NXT for chemiluminescence-based in vitro diagnostics, alongside end-to-end Contract Services for diagnostics product realization.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Energy density above 390Wh/kg for lithium-ion batteries
+2 more records
Product overview1 text field

AnteoTech is a Brisbane-based company (ASX: ADO) operating across two distinct technology platforms: Life Sciences and Advanced Battery Technologies. In Life Sciences, the company offers AnteoBind as its core diagnostic brand, with AnteoBind NXT representing next-generation development expanding into chemiluminescence. Contract Services support end-to-end product realization. In Advanced Battery Technologies, Anteo X serves as the foundational battery technology platform, while Ultranode™ (including UltraNode 95 and Ultranode X variants) provides silicon anode solutions for enhanced energy density. Anteo S represents a cross-linking separator product for battery safety applications.

Product and service6 records
1Anteo X
CategoryAdvanced Battery Technologies
Description

Advanced battery technology platform that enables manufacturing partners to build lighter, more compact and cost-effective lithium-ion batteries. Targeted at lithium-ion battery manufacturers.

2Ultranode (UltraNode 95)
CategoryAdvanced Battery Materials
Description

Silicon anode technology for lithium-ion batteries delivering significantly higher energy densities than conventional graphite anodes. UltraNode 95 achieves approximately 2,000-2,400mAh/g vs graphite's ~371mAh/g limit. Targeted at battery manufacturers serving drone, defense, EV and medical device applications.

3AnteoBind
CategoryLife Sciences Diagnostics
Description

Proprietary diagnostic binding technology platform enabling niche and novel diagnostic products addressing global challenges in healthcare, agriculture and veterinary sciences. Targeted at diagnostic manufacturers and life sciences companies.

4AnteoBind NXT
CategoryLife Sciences Diagnostics
Description

Next-generation diagnostic product development expanding into the chemiluminescence market for in vitro diagnostics, delivering improved speed and accuracy in healthcare diagnostics. Targeted at diagnostic assay developers and immunoassay manufacturers.

5Contract Services
CategoryLife Sciences Services
Description

End-to-end contract services spanning initial product concept through to successful product realization and distribution for diagnostics and life sciences. Targeted at life sciences companies seeking outsourced product development support.

6Anteo S Cross-linking Separator
CategoryAdvanced Battery Materials
Description

Cross-linking separator product combined with ceramic coated separator technology to improve lithium-ion battery safety and performance. Targeted at lithium-ion battery manufacturers globally.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
1Cosmo Bio
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-05-28
Description

Tokyo-listed Cosmo Bio appointed as Japanese distributor for AnteoBind products, targeting growth in the immunoassay market. Distribution deal opens Japan sales channel.

anteotech.com
2Xerobrid Corporation
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-26
Description

Strategic collaboration and sales agreement combining AnteoTech's Anteo S cross-linking separator product with Xerobrid's ceramic coated separator technology to improve battery safety and performance. Four companies in South Korea are currently evaluating Anteo S for integration and scale-up, with a comprehensive three-year agreement expected within 120 days.

theaustralian.com.au
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Market expansion partnership with Black Diamond Structures in the US for battery sector distribution.

4South Korean Distributors
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partners in South Korea for battery market expansion.

ph.investing.com
5Battery Innovation Center (Indiana)
Strategic tierCoreTypeTechnology or Integration
Description

Independent validation of UltraNode 95 silicon anode technology confirming integration into existing manufacturing processes without major changes, supporting pathway toward cost-effective commercial production.

ph.investing.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Trial of Ultranode for high-value medical device battery market targeting.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

100% active silicon 3D-cell architecture for high energy-density lithium-ion batteries, targeting consumer electronics and EVs. Comparable to AnteoTech on silicon-based energy-density leadership and pursued licensing/manufacturing partnerships with Tier-1 players.

TypeBroad incumbent
Description

Spun-off life sciences and diagnostics business (formerly PerkinElmer) covering immunoassays, chemiluminescence platforms and reagents used across clinical diagnostics. Directly comparable to AnteoBind NXT's chemiluminescence expansion strategy.

TypeDirect peer
Description

US-listed silicon anode battery company targeting defense, drone and aviation markets with high energy-density cells. Closest functional comparable to AnteoTech's UltraNode 95 silicon anode offering on technology, customer profile (defense OEMs) and performance metric (Wh/kg).

TypeBroad incumbent
Description

Large global developer of life-sciences research reagents and diagnostic tools including proteins, antibodies and assays. Comparable to AnteoTech's AnteoBind diagnostic reagents/IVD business on customer base (research and diagnostic labs) and product category (binding reagents).

TypeDirect peer
Description

Developer of silicon-dominant anode materials for lithium-ion batteries serving automotive and consumer electronics. Directly comparable to AnteoTech on silicon anode chemistry, drop-in manufacturing approach, and licensing-style commercial model.

TypeEmerging player
Description

Canadian-listed developer of silicon anode materials for lithium-ion batteries with focus on cost-effective manufacturing processes. Comparable emerging player to AnteoTech on silicon anode chemistry and on partnering with cell manufacturers.

TypeBroad incumbent
Description

Global supplier of protein research tools, antibodies and diagnostic binding reagents, now part of Danaher. Comparable to AnteoTech's AnteoBind diagnostic binding technology on customer overlap (research/diagnostic labs) and binding-reagent product positioning.

TypeDirect peer
Description

Silicon battery materials company producing silicon-carbon anode powders for automotive and consumer battery applications. Direct materials-level peer to AnteoTech's UltraNode silicon anode active material strategy.

TypeBroad incumbent
Description

Global diagnostics company with broad immunoassay and clinical chemistry menu, including chemiluminescence-based platforms. Comparable to AnteoTech's diagnostic expansion strategy serving clinical labs and reference laboratories worldwide.

TypeDirect peer
Description

Silicon-dominant anode technology for fast-charging, high energy-density Li-ion batteries, primarily serving EV applications. Closely comparable to AnteoTech on silicon anode IP and on a partner-licensed commercialization model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AnteoTech

Advanced Battery Materials & Life Sciences Diagnosticsanteotech.com

AnteoTech is an Australian (ASX: ADO) materials and diagnostics company that develops silicon anode battery technologies (UltraNode, Anteo X, Anteo S) for drone, defense, and medical device applications, and AnteoBind diagnostic binding products for healthcare, agriculture, and veterinary markets, selling via channel partners globally.

What AnteoTech does

AnteoTech Ltd (ASX: ADO) is a Brisbane-based public company founded in 1995 that operates two distinct technology platforms. In Life Sciences it develops and commercializes diagnostic binding products under the AnteoBind brand, including the next-generation AnteoBind NXT platform expanded into chemiluminescence, serving healthcare, agriculture, and veterinary diagnostics customers such as the Serum Institute. In Advanced Battery Technologies it develops UltraNode silicon anode materials (notably UltraNode 95, with stated capacities of 2,000-2,400 mAh/g versus ~371 mAh/g for graphite, enabling energy densities above 390 Wh/kg), the Anteo X platform, and the Anteo S cross-linking separator product, with go-to-market focus on drone, defense, and medical device battery applications and recent independent validation by the Battery Innovation Center in Indiana. Revenue mechanics combine product sales (AnteoBind diagnostics), licensing/royalty arrangements (battery materials with partners such as Xerobrid), and an end-to-end contract services offering, distributed through a small but expanding network of channel partners including Cosmo Bio in Japan, Black Diamond Structures in the US, and South Korean battery distributors.

The company is small (11-50 employees), headquartered at Brisbane Technology Park in Eight Mile Plains, and has undergone cost-base restructuring alongside an AUD 3.5 million capital raise in early 2026 to extend operational runway and accelerate sales conversion. Strategic activity in mid-2026 has centred on commercialization: an UltraNode 95 product launch, a strategic collaboration with Xerobrid Corporation pairing Anteo S with ceramic-coated separators, a Cosmo Bio distribution deal opening Japan, and JDAs being negotiated with US defense-aligned battery manufacturers. The current share price sits near 52-week lows at AUD 0.012, reflecting investor concern about the speed of revenue conversion, while named partners and validation milestones support an active commercialization pipeline.

AnteoTech firmographics

Firmographics
Name
AnteoTech
Legal name
AnteoTech Ltd
Website
https://anteotech.com
Company type
Public
Founded year
1995
Operating status
Operating
Headcount range
11–50 employees
Short description
AnteoTech is an Australian (ASX: ADO) materials and diagnostics company that develops silicon anode battery technologies (UltraNode, Anteo X, Anteo S) for drone, defense, and medical device applications, and AnteoBind diagnostic binding products for healthcare, agriculture, and veterinary markets, selling via channel partners globally.
Ownership category
akta.pro rank

Where AnteoTech is headquartered

Location

Headquarters

HQ city
Eight Mile Plains
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

AnteoTech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Battery Technology Products: Revenue from battery separator technology (Anteo S) and silicon anode products (UltraNode). Strategic collaboration and sales agreement with Xerobrid Corporation for separator technology.
  2. Life Sciences Diagnostics: Revenue from diagnostic products including AnteoBind and AnteoBind NXT, with expansion into chemiluminescence market. Serum Institute order mentioned as key revenue catalyst.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

AnteoTech product offering

Product offering

Core offering

AnteoTech develops and commercializes two technology platforms: (1) Advanced Battery Technologies, including silicon anode materials (Ultranode/UltraNode 95), a battery technology platform (Anteo X), and a cross-linking separator product (Anteo S); and (2) Life Sciences diagnostics, including the AnteoBind platform and next-generation AnteoBind NXT for chemiluminescence-based in vitro diagnostics, alongside end-to-end Contract Services for diagnostics product realization.

Product overview

AnteoTech is a Brisbane-based company (ASX: ADO) operating across two distinct technology platforms: Life Sciences and Advanced Battery Technologies. In Life Sciences, the company offers AnteoBind as its core diagnostic brand, with AnteoBind NXT representing next-generation development expanding into chemiluminescence. Contract Services support end-to-end product realization. In Advanced Battery Technologies, Anteo X serves as the foundational battery technology platform, while Ultranode™ (including UltraNode 95 and Ultranode X variants) provides silicon anode solutions for enhanced energy density. Anteo S represents a cross-linking separator product for battery safety applications.

Differentiator

Problem solved

Functional benefit

Brands

  • Anteo X: Advanced battery technology product line
  • Ultranode
  • AnteoBind
  • AnteoBind NXT

Products and services

  • Anteo X Advanced battery technology platform that enables manufacturing partners to build lighter, more compact and cost-effective lithium-ion batteries. Targeted at lithium-ion battery manufacturers.
  • Ultranode (UltraNode 95) Silicon anode technology for lithium-ion batteries delivering significantly higher energy densities than conventional graphite anodes. UltraNode 95 achieves approximately 2,000-2,400mAh/g vs graphite's ~371mAh/g limit. Targeted at battery manufacturers serving drone, defense, EV and medical device applications.
  • AnteoBind Proprietary diagnostic binding technology platform enabling niche and novel diagnostic products addressing global challenges in healthcare, agriculture and veterinary sciences. Targeted at diagnostic manufacturers and life sciences companies.
  • AnteoBind NXT Next-generation diagnostic product development expanding into the chemiluminescence market for in vitro diagnostics, delivering improved speed and accuracy in healthcare diagnostics. Targeted at diagnostic assay developers and immunoassay manufacturers.
  • Contract Services End-to-end contract services spanning initial product concept through to successful product realization and distribution for diagnostics and life sciences. Targeted at life sciences companies seeking outsourced product development support.
  • Anteo S Cross-linking Separator Cross-linking separator product combined with ceramic coated separator technology to improve lithium-ion battery safety and performance. Targeted at lithium-ion battery manufacturers globally.

Quantifiable outcome

  • Energy density above 390Wh/kg for lithium-ion batteries
  • +2 more outcomes

Companies that use AnteoTech

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

AnteoTech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

AnteoTech partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Cosmo BiocoreChannel Partner/ Reseller/ Distributor · 28 May 2026Tokyo-listed Cosmo Bio appointed as Japanese distributor for AnteoBind products, targeting growth in the immunoassay market. Distribution deal opens Japan sales channel.
  • Xerobrid CorporationcoreStrategic or Co-development Partner · 26 May 2026Strategic collaboration and sales agreement combining AnteoTech's Anteo S cross-linking separator product with Xerobrid's ceramic coated separator technology to improve battery safety and performance. Four companies in South Korea are currently evaluating Anteo S for integration and scale-up, with a comprehensive three-year agreement expected within 120 days.
  • Black Diamond StructuresminorChannel Partner/ Reseller/ DistributorMarket expansion partnership with Black Diamond Structures in the US for battery sector distribution.
  • South Korean DistributorsminorChannel Partner/ Reseller/ DistributorDistribution partners in South Korea for battery market expansion.
  • Battery Innovation Center (Indiana)coreTechnology or IntegrationIndependent validation of UltraNode 95 silicon anode technology confirming integration into existing manufacturing processes without major changes, supporting pathway toward cost-effective commercial production.
  • WyonminorStrategic or Co-development PartnerTrial of Ultranode for high-value medical device battery market targeting.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

AnteoTech competitors and assessment

Company assessment

Direct peers

  • Enovix Corporation: 100% active silicon 3D-cell architecture for high energy-density lithium-ion batteries, targeting consumer electronics and EVs. Comparable to AnteoTech on silicon-based energy-density leadership and pursued licensing/manufacturing partnerships with Tier-1 players.
  • Amprius Technologies: US-listed silicon anode battery company targeting defense, drone and aviation markets with high energy-density cells. Closest functional comparable to AnteoTech's UltraNode 95 silicon anode offering on technology, customer profile (defense OEMs) and performance metric (Wh/kg).
  • Sila Nanotechnologies: Developer of silicon-dominant anode materials for lithium-ion batteries serving automotive and consumer electronics. Directly comparable to AnteoTech on silicon anode chemistry, drop-in manufacturing approach, and licensing-style commercial model.
  • Group14 Technologies: Silicon battery materials company producing silicon-carbon anode powders for automotive and consumer battery applications. Direct materials-level peer to AnteoTech's UltraNode silicon anode active material strategy.
  • Enevate Corporation: Silicon-dominant anode technology for fast-charging, high energy-density Li-ion batteries, primarily serving EV applications. Closely comparable to AnteoTech on silicon anode IP and on a partner-licensed commercialization model.

Broad incumbents

  • Revvity: Spun-off life sciences and diagnostics business (formerly PerkinElmer) covering immunoassays, chemiluminescence platforms and reagents used across clinical diagnostics. Directly comparable to AnteoBind NXT's chemiluminescence expansion strategy.
  • Bio-Techne Corporation: Large global developer of life-sciences research reagents and diagnostic tools including proteins, antibodies and assays. Comparable to AnteoTech's AnteoBind diagnostic reagents/IVD business on customer base (research and diagnostic labs) and product category (binding reagents).
  • Abcam (Danaher): Global supplier of protein research tools, antibodies and diagnostic binding reagents, now part of Danaher. Comparable to AnteoTech's AnteoBind diagnostic binding technology on customer overlap (research/diagnostic labs) and binding-reagent product positioning.
  • QuidelOrtho: Global diagnostics company with broad immunoassay and clinical chemistry menu, including chemiluminescence-based platforms. Comparable to AnteoTech's diagnostic expansion strategy serving clinical labs and reference laboratories worldwide.

Emerging players

  • NEO Battery Materials: Canadian-listed developer of silicon anode materials for lithium-ion batteries with focus on cost-effective manufacturing processes. Comparable emerging player to AnteoTech on silicon anode chemistry and on partnering with cell manufacturers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

AnteoTech social profiles

Digital presence

AnteoTech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AnteoTech leadership team

Management profile

Number of profiles

Profiles2 records

AnteoTech funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AnteoTech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AnteoTech

What does AnteoTech do?

AnteoTech develops and commercializes two technology platforms: (1) Advanced Battery Technologies, including silicon anode materials (Ultranode/UltraNode 95), a battery technology platform (Anteo X), and a cross-linking separator product (Anteo S); and (2) Life Sciences diagnostics, including the AnteoBind platform and next-generation AnteoBind NXT for chemiluminescence-based in vitro diagnostics, alongside end-to-end Contract Services for diagnostics product realization.

Is AnteoTech a public or private company?

AnteoTech is a public company. It is classified as public and is currently operating.

When was AnteoTech founded?

AnteoTech was founded in 1995. It employs 11 to 50 people.

Where is AnteoTech based?

AnteoTech is headquartered in Eight Mile Plains, Australia, in the Oceania region.

How does AnteoTech make money?

Two revenue lines are on record. Battery Technology Products are the primary driver. The others are life Sciences Diagnostics.

Who are AnteoTech's main competitors?

Direct peers on record are Enovix Corporation, Amprius Technologies, Sila Nanotechnologies, Group14 Technologies and Enevate Corporation. Broad incumbents are Revvity, Bio-Techne Corporation, Abcam (Danaher) and QuidelOrtho. NEO Battery Materials is listed as an emerging player.

Does AnteoTech have an API?

No public API is recorded for AnteoTech.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Investing.comEarnings Call Transcripts - Investing.comAnteoTech reported FY2026 revenue of AUD 2.6 million, down year over year due to a missed Serum Institute order and timing issues. The company expects the delayed order to be booked in FY2027 and highlighted a capital-light, partnership-driven strategy. Management said sales execution is the key KPI for FY2027.AInvestAnteotech Ltd - Next generation battery agreement with AirspeederAnteoTech Ltd signed a strategic collaboration with Airspeeder to develop next-generation batteries for eVTOL applications, using its silicon anode technology. The partnership targets the global battery market, projected to reach $180 billion by 2030, and aims to reduce weight and cost.The AustralianAnteoTech seals battery separator tech dealAnteoTech and Xerabrid Corporation have entered a commercial collaboration to jointly market, manufacture, and sell an advanced battery separator that utilizes AnteoTech's proprietary cross-linking technology. The combined product has demonstrated high thermal stability with zero shrinkage at 150°C, allowing for thinner separators that increase energy density and safety in battery applications. Both companies plan to supply initial samples by October 2026 and showcase the technology at the US Battery Show.AInvestAnteotech Ltd-appointment of CFO and company secretaryAnteoTech Ltd (ASX:ADO) has appointed Andrew Cook as its Chief Financial Officer and Company Secretary, bringing over 20 years of financial experience in energy and renewables sectors. Cook previously served as CFO of Entyr Limited (ASX:ETR), an ASX-listed clean technology company, and his appointment follows an earlier interim CFO and Company Secretary role. The company states this appointment strengthens its executive leadership during a critical development phase for its clean energy and life sciences operations.ESS NewsAnteoTech launches primer additive designed to boost battery performanceAustralian battery tech company AnteoTech has launched Anteo C, a PFAS-free, water-based cross-linker additive for primer coatings in lithium-ion batteries that stabilizes electrode coatings and enables the use of lower-cost water-based binder systems. The company has shipped a 20-liter sample of Anteo C to a South Korean manufacturer for evaluation in water-based lithium iron phosphate cathode production. AnteoTech's managing director described the South Korean market entry as a positive development, with additional customer opportunities and commercial discussions underway globally.Pv-magazine-australiaAnteoTech launches primer additive designed to boost battery performanceQueensland-based AnteoTech has launched Anteo C, a PFAS-free cross-linker additive designed to stabilize primer coatings in lithium-ion battery manufacturing. The company has shipped samples to a South Korean manufacturer for evaluation and is engaging with potential customers globally to commercialize the product.Small CapsAnteoTech Launches Anteo C Performance-Enhancing Primer Additive for Lithium-Ion BatteriesAnteoTech has launched Anteo C, a performance-enhancing primer coating additive for lithium-ion batteries, following successful laboratory-scale testing by a South Korean contract coating company. The company has progressed to manufacturing-scale trials with a 20L sample and is working with distributor Kangshin Industrial Co to expand customer engagement in South Korea while also targeting India as a key market. AnteoTech expects both Anteo C and its sister product Anteo S to drive growth in FY27.KalkineAnteoTech Targets Battery Breakthrough with New Lithium-Ion Primer Additive LaunchAnteoTech, an Australian ASX-listed advanced-materials company, has launched "Anteo C", a PFAS-free and water-based primer additive designed to improve adhesion and performance in lithium-ion battery electrode manufacturing. The company is currently running pilot-scale trials with partners and customers in Korea and India, two key regions in the global battery supply chain. The launch represents a tangible step toward commercializing the company's Anteo Battery Technology portfolio, though pilot outcomes do not guarantee commercial adoption.The Sydney Morning HeraldASX Runners: White Energy, Thrive Tribe, AnteoTech & HarvestWhite Energy Company's share price surged 309% after it announced plans to acquire two metallurgical coal assets in the US and Queensland, including the Lolley No.1 project in Alabama and Tin Hut Creek in the Surat Basin. The company raised $15 million to fund the deals, with first production expected 12 months after recommissioning.